In the context of its multiple modeling ameliorative effects, we have focused on the ameliorative effects also exerted on neurexin-1 and neuroligins in response to Parkinson’s and memory impairment, which in turn restore impairments synaptic plasticity [55, 100]. This evidence concerns the gene NRXN1 and Parkinson disease.